Overview
Valiant Laboratories Limited is a key player in the Active Pharmaceutical Ingredient (API) manufacturing space, specifically focusing on paracetamol production.
The company traces its roots back to 1980 and transitioned from a partnership firm to a public limited company in 2021.
With an annual installation capacity of 9,000 MTPA, its manufacturing plant is a significant asset situated in Maharashtra.
Valiant has expanded its business reach through a subsidiary, Valiant Advanced Sciences Private Limited, established in July 2022 to diversify into new areas.
The company raised funds through a public issue, enhancing its capital base and reinforcing growth prospects.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
372 Cr
- Volatility
Moderate Risk
- P/E Ratio
-70.6
- Industry P/E
32.3
- PEG Ratio
—
- P/B Ratio
1.2
- 52W High
114.72
- 52W Low
50.00
Financial Ratios
Sales CAGR
- 1Y
- -26.74%
- 3Y
- -22.95%
- 5Y
- —
- 10Y
- —
Profit CAGR
- 1Y
- -787.50%
- 3Y
- —
- 5Y
- —
- 10Y
- —
ROE
- TTM
- 1.60%
- 3Y
- 4.76%
- 5Y
- 11.65%
- 10Y
- —
ROCE
- TTM
- 1.50%
- 3Y
- 4.81%
- 5Y
- 12.97%
- 10Y
- —
Technicals
Oscillators
Bearish
Bearish
8
Neutral
2
Bullish
4
Overall
Bullish
Bearish
12
Neutral
2
Bullish
32
Moving Averages
Bullish
Bearish
4
Neutral
0
Bullish
28
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
